February 24, 2005

The Honorable Jack Hart

Chair, Committee on Economic Development

and Emerging Technologies

Massachusetts State Senate

Room 109C , State House

Boston, MA 02133

Dear Mr. Chairman:

On behalf of the directors and officers of the Massachusetts Medical Device Industry Council (MassMEDIC), I am writing in support of the economic benefits related to stem cell research in the Commonwealth of Massachusetts.

As you may know, the medical device industry is a vital part of Massachusetts’ economy. With over 21,000 jobs, 225 manufacturing companies, $5 billion in annual sales and a well-established supply base, Massachusetts is home to the second largest concentration of medical device production in the United States. The strength and position of the medical device industry in Massachusetts depends, in large measure, on the technologies developed and research performed at the region’s academic institutions, teaching hospitals and companies. These new and innovative medical technologies are directly linked to the vibrancy of the state’s life sciences cluster.

MassMEDIC believes that supporting stem cell research under appropriate guidelines will bolster the Commonwealth’s preeminent life science sector and would be an important component of a sound economic development strategy. States such as California and New Jersey have already taken steps to encourage stem cell research, raising the competitive profile of their life sciences sectors.

MassMEDIC recognizes that stem cell research raises many questions beyond economics, which are currently being debated. However, passage of stem cell research legislation would be a clear signal to all members of the life science industry – medical devices, biotech and pharmaceutical – that Massachusetts is serious about providing a climate for growth and expansion. MassMEDIC urges your support for this important initiative.

Thank you for considering MassMEDIC’s position on this issue.

Sincerely,

Thomas J. Sommer

President